Related Experiment Video
Updated: Mar 6, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
Rapid Analysis of Outcomes Using the Systemic Anti-Cancer Therapy (SACT) Dataset
R Pathak1, M Wallington2, C Saunders3
1University of Manchester, Manchester, UK.
The Systemic Anti-Cancer Therapy dataset accurately tracks patient outcomes for cancer drug treatments. This resource is valuable for analyzing survival data in patients receiving chemotherapy.
Area of Science:
- Oncology
- Health Informatics
Background:
- The Systemic Anti-Cancer Therapy dataset is a crucial resource for cancer research.
- Accurate patient outcome data is essential for evaluating treatment efficacy.
Purpose of the Study:
- To audit the accuracy of the Systemic Anti-Cancer Therapy dataset.
- To assess its utility for analyzing patient outcomes in metastatic colorectal cancer treated with monoclonal antibodies.
Main Methods:
- Data accuracy audit of the Systemic Anti-Cancer Therapy dataset.
- Analysis of patient outcomes for those receiving Cancer Drug Fund-funded monoclonal antibodies.
Main Results:
- The Systemic Anti-Cancer Therapy dataset demonstrates accuracy for outcome analysis.
- The dataset is suitable for evaluating treatments like monoclonal antibodies for metastatic colorectal cancer.
Conclusions:
- The Systemic Anti-Cancer Therapy dataset is a valuable resource for rapid survival outcome analysis.
- It supports the evaluation of chemotherapy treatments and targeted therapies.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers